The
following securities were excluded from the computation of diluted net loss per share attributable to common shareholders for the three
and nine months ended September 30, 2024 and 2023, because including them would have been anti-dilutive:
Schedule
of Securities Excluded from the Computation of Diluted Net Loss Per Share Attributable to Common Shareholders
| | |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| | |
Three
Months Ended September 30, | | |
Nine
Months Ended September 30, | |
| | |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| Series X preferred stock | |
| 51,055 | | |
| 51,055 | | |
| 51,055 | | |
| 51,055 | |
| Unvested restricted stock units | |
| 1,471 | | |
| 95,504 | | |
| 1,471 | | |
| 95,504 | |
| Common stock warrants | |
| 10,281,626 | | |
| 81,623 | | |
| 10,281,626 | | |
| 81,623 | |
| Convertible Notes | |
| — | | |
| 669,173 | | |
| — | | |
| 669,173 | |
| Total | |
| 10,334,152 | | |
| 897,356 | | |
| 10,334,152 | | |
| 897,356 | |
|